These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 8869100)
1. A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome. Dockhorn-Dworniczak B; Wolff J; Poremba C; Schäfer KL; Ritter J; Gullotta F; Jürgens H; Böcker W Eur J Cancer; 1996 Jul; 32A(8):1359-65. PubMed ID: 8869100 [TBL] [Abstract][Full Text] [Related]
2. [Description of a new TP53 gene germline mutation in a family with the Li-Fraumeni syndrome. Genetic counselling to healthy mutation carriers]. Balmaña J; Nomdedéu J; Díez O; Sabaté JM; Balil A; Pericay C; López López JJ; Brunet J; Baiget M; Alonso C Med Clin (Barc); 2002 Oct; 119(13):497-9. PubMed ID: 12406399 [TBL] [Abstract][Full Text] [Related]
3. High frequency of germline p53 mutations in childhood adrenocortical cancer. Wagner J; Portwine C; Rabin K; Leclerc JM; Narod SA; Malkin D J Natl Cancer Inst; 1994 Nov; 86(22):1707-10. PubMed ID: 7966399 [TBL] [Abstract][Full Text] [Related]
4. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S; JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041 [TBL] [Abstract][Full Text] [Related]
5. Familial gastric cancer and Li-Fraumeni syndrome. Corso G; Pedrazzani C; Marrelli D; Pinto E; Roviello F Eur J Cancer Care (Engl); 2010 May; 19(3):377-81. PubMed ID: 19674071 [TBL] [Abstract][Full Text] [Related]
6. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families. Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494 [TBL] [Abstract][Full Text] [Related]
7. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile. Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001 [TBL] [Abstract][Full Text] [Related]
8. A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla. Patrikidou A; Bennett J; Abou-Sleiman P; Delhanty JD; Harris M Oral Oncol; 2002 Jun; 38(4):383-90. PubMed ID: 12076704 [TBL] [Abstract][Full Text] [Related]
9. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes. Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481 [TBL] [Abstract][Full Text] [Related]
10. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735 [TBL] [Abstract][Full Text] [Related]
11. Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family. Güran S; Tunca Y; Imirzalioğlu N Cancer Genet Cytogenet; 1999 Sep; 113(2):145-51. PubMed ID: 10484981 [TBL] [Abstract][Full Text] [Related]
12. Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours. Sedlacek Z; Kodet R; Kriz V; Seemanova E; Vodvarka P; Wilgenbus P; Mares J; Poustka A; Goetz P Br J Cancer; 1998 Apr; 77(7):1034-9. PubMed ID: 9569035 [TBL] [Abstract][Full Text] [Related]
13. [A method for detection of germinal mutations in the p53 tumor suppressor gene]. Sedlácek Z; Kríz V; Seemanová E; Vlcek C; Maríková T; Mares J; Goetz P Cas Lek Cesk; 1996 Dec; 135(23):762-7. PubMed ID: 9005123 [TBL] [Abstract][Full Text] [Related]
15. The Li-Fraumeni syndrome: an inherited susceptibility to cancer. Evans SC; Lozano G Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689 [TBL] [Abstract][Full Text] [Related]
16. Three germline mutations in the TP53 gene. Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756 [TBL] [Abstract][Full Text] [Related]
17. Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2. Huusko P; Castrén K; Launonen V; Soini Y; Pääkkönen K; Leisti J; Vähäkangas K; Winqvist R Cancer Genet Cytogenet; 1999 Jul; 112(1):9-14. PubMed ID: 10432928 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining. MacGeoch C; Turner G; Bobrow LG; Barnes DM; Bishop DT; Spurr NK J Med Genet; 1995 Mar; 32(3):186-90. PubMed ID: 7783166 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population. Gallardo-Alvarado LN; Tusié-Luna MT; Tussié-Luna MI; Díaz-Chávez J; Segura YX; Bargallo-Rocha E; Villarreal C; Herrera-Montalvo LA; Herrera-Medina EM; Cantu-de Leon DF BMC Cancer; 2019 Feb; 19(1):118. PubMed ID: 30709381 [TBL] [Abstract][Full Text] [Related]
20. Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li-Fraumeni syndrome. Etzold A; Schröder JC; Bartsch O; Zechner U; Galetzka D Fam Cancer; 2015 Mar; 14(1):161-5. PubMed ID: 25226867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]